Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Disorders of the Colon
Do you continue antiplatelet/anticoagulant therapy in patients with hemodynamically stable diverticular bleeding to improve localization and treatment of source of bleeding?
Related Questions
What is your approach to treatment of patients with fulminant C difficile infection who required ileostomy creation or colectomy?
How do you approach the treatment of microscopic colitis?
Has your institution and/or antimicrobial stewardship program incorporated a selective antibiotic approach to treatment of left-sided uncomplicated diverticulitis in immunocompetent patients?
Under what circumstances would you recommend early fecal microbiota transplantation over antibiotic treatment or bezlotoxumab in a patient with recurrent C. difficile infection?
What is your approach to duration of fidaxomicin in a patient receiving treatment for first C difficile infection while also receiving concurrent antibiotics for an infection?
What is your approach to choosing a particular advanced therapy based on patient or disease factors when initiating treatment for moderate-severe IBD?
How long do you continue antibiotics after cholecystostomy tube placement for acute cholecystitis?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
What recommendations do you provide to advance an inpatient’s oral tolerance in the setting of an unspecified vomiting disorder?
How do you approach managing nausea and GI side effects when initiating methotrexate?
